Lymphedema affects more than 1 in 1000 Americans, most commonly resulting from breast cancer surgery. Conservative treatments, such as compression garments, combined decongestive therapy (CDT), and pneumatic compression pumps are the current standard of care. Despite the wide availability of these therapies, lymphedema remains undertreated worldwide. We investigated whether third-party insurance coverage may be a barrier to obtaining conservative treatment in the United States.